Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Prof who wrote (6609)	10/19/1998 4:58:00 PM
From: TokyoMex	Read Replies (2) \| Respond to of 119973

ANIK ANIK develops, manufactures and commercializes therapeutic products based on hyaluronic acid (HA) used to promote the protection and healing of bone, cartilage and soft tissue. For the 6 months ended 6/30/98, revenues rose 68% to $7.4M. Net income totalled $2.8M, up from $553K. Revenues reflect increased sales of AMVISC products and ORTHOVISC. Net income also reflects an improved gross profit as a percentage of sales, and higher interest income. Anika Therapeutics, Inc. 236 West Cummings Park Woburn, MA 01801 Phone: (781) 932-6616 Fax: (781) 935-4120 -------------------------------------------------------------------------------- Sector: Healthcare Industry: Biotechnology & Drugs Employees: 55 Market Cap (Mil) $ : 119.51 Complete Financials: Jun 1998 Updated: 10/17/98 Earnings Announcement: NA OFFICERS: D. Swann Ph.D., Chmn., J.M. Engle, Pres./CEO, S.Moran, VP-Fin./CFO/CAO/Treas., S. Kinney, VP-Ops., J. KuoPh.D., VP, E. Ross Jr., VP, M. Slater, VP. TRANSFER AGENT:First National Bank of Boston. Company inc. 1992 in MA.Direct inquiries to: Sean Moran, VP-Fin./CFO/CAO/Treas. Key Ratios & Statistics Price & Volume Recent Price $ 12.00 52 Week High $ 19.13 52 Week Low $ 6.75 Avg Daily Vol (Mil) 0.07 Beta 1.42 Share Related Items Mkt. Cap. (Mil) $ 119.51 Shares Out (Mil) 9.96 Float (Mil) 6.00 Dividend Information Yield % 0.00 Annual Dividend 0.00 Payout Ratio (TTM) % 0.00 Financial Strength Quick Ratio (MRQ) 12.70 Current Ratio (MRQ) 14.35 LT Debt/Equity (MRQ) 0.00 Total Debt/Equity (MRQ) 0.00 Valuation Ratios Price/Earnings (TTM) 12.54 Price/Sales (TTM) 5.85 Price/Book (MRQ) 3.97 Price/Cash Flow (TTM) 14.44 Per Share Data Earnings (TTM) $ 0.96 Sales (TTM) $ 2.05 Book Value (MRQ) $ 3.02 Cash Flow (TTM) $ 0.83 Cash (MRQ) $ 2.37 Mgmt Effectiveness Return on Equity (TTM) 31.19 Return on Assets (TTM) 26.36 Return on Investment (TTM) 29.26 Profitability Gross Margin (TTM) % 63.53 Operating Margin (TTM) % 33.25 Profit Margin (TTM) % 37.70 Mil = Millions MRQ = Most Recent Quarter TTM = Trailing Twelve Months Glossary of financial terms.